You may also be interested in:
Mammalian
Commercial Supply Services
Manufacturing: GMP Drug Substance
Manufacturing: GMP Drug Product
Watch this video
Watch now
Latest briefing from the Knowledge Center
Dolphin expansion rendering
Interview
Q&A on large-scale commercial expansion at Lonza's Stein facility
Are you a biopharmaceutical or biotech professional looking to stay ahead in the industry? Download...
AI-Enabled Route Scouting Service Scientists
Technical/Service brief
AI-Enabled Route Scouting Service Technical Brief
Small molecule active pharmaceutical ingredients (APIs) are becoming more molecularly complex,...
biologics manufacturing
CDMO Notes Blog post
Unlocking Efficiency in Biologics Manufacturing with a Novel Process Intensification Platform
Dr. Ruth Rowland-Jones explains how Lonza is revolutionizing biologics with new Process Analytics...
biologics manufacturing
CDMO Notes Blog post
Advanced Genetic Analysis & The Future of Next-Generation Sequencing
Dr. Neil Taylor explains Lonza’s approach to advanced genetic analysis - from new technologies to...
Andrea Cubitt, Ph.D., Vice President External Scientific Alliances and Intellectual Property, aTyr Pharma
Article
A Small Biotech Recognizes the Importance in How You Think of Manufacturing in Selecting a CDMO
Manufacturing is crucial to the success of any drug development project but is too often overlooked....
Monoclonal Antibody Molecule
Article
Lonza Shows Flexibility with Ibex® Design Platform to Accommodate tRNA Synthetase-Derived mAbs
aTyr Pharma is a clinical stage biotech focused on translating findings from a proprietary tRNA...
PBPK_scientist-in-lab-with-monitor
Webinar (on-demand)
PBPK Modeling for Identifying and Mitigating Absorption Risks in Early Drug Development
When coupled with in vitro measurements, PBPK modeling is effective in early development for 1)...
Drug Substance API-HPAPI
White paper
Using Synthesis and Route Design Technology to Approach API Complexity
Small molecule active pharmaceutical ingredients (APIs) continue to grow more complex. As a result,...
Women in lab with tablet
Article
The Power of Artificial Intelligence and Route Scouting to Navigate API Complexity
As active pharmaceutical ingredients (APIs) continue to grow more complex, process chemists must...
Article
Transparent Communication Supports Tech Transfers of Cis-targeted Immunotherapies
Asher Biotherapeutics embarked on a search for a contract development and manufacturing organization...
Article
Cis-targeted Immunotherapies Need Large CDMO Expertise but also Flexibility
Asher Biotherapeutics is developing a pipeline of cis-targeted immunotherapies that selectively...
Webinar (on-demand)
Accelerate your ADC Journey: Filling the Need for Integrated Bioconjugate Solutions
Lonza is further reshaping the ADC landscape by introducing new Drug Product capabilities that...